Log In
Print
BCIQ
Print
Print this Print this
 

RG7652

  Manage Alerts
Collapse Summary General Information
Company Roche
DescriptionHuman mAb against proprotein convertase subtilisin/kexin type 9 (PCSK9)
Molecular Target Proprotein convertase subtilisin/kexin type 9 (PCSK9)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard IndicationHyperlipidemia
Indication DetailsTreat hyperlipidemia
Regulatory Designation

Partner

Chugai Pharmaceutical Co. Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today